National Health Investors (NYSE:NHI) Price Target Raised to $58.00 at Truist Financial

National Health Investors (NYSE:NHI - Get Free Report) had its price target upped by analysts at Truist Financial from $55.00 to $58.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The brokerage presently has a "hold" rating on the real estate investment trust's stock. Truist Financial's price objective indicates a potential downside of 2.23% from the company's previous close.

A number of other research analysts have also recently issued reports on the stock. BMO Capital Markets upgraded shares of National Health Investors from a "market perform" rating to an "outperform" rating and set a $67.00 target price for the company in a research note on Tuesday, March 12th. Wedbush lifted their target price on shares of National Health Investors from $64.00 to $66.00 and gave the stock an "outperform" rating in a report on Monday, March 18th. Wells Fargo & Company upgraded shares of National Health Investors from an "equal weight" rating to an "overweight" rating and upped their price objective for the company from $55.00 to $63.00 in a research report on Monday, February 26th. Deutsche Bank Aktiengesellschaft started coverage on shares of National Health Investors in a research report on Tuesday, January 30th. They issued a "buy" rating and a $69.00 price objective for the company. Finally, StockNews.com cut National Health Investors from a "buy" rating to a "hold" rating in a report on Tuesday. Five equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, National Health Investors currently has an average rating of "Hold" and a consensus target price of $60.50.

National Health Investors Stock Performance

NHI stock traded down $0.57 during trading on Thursday, reaching $59.32. 145,095 shares of the stock were exchanged, compared to its average volume of 177,009. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.90. The stock has a 50 day simple moving average of $57.26 and a 200-day simple moving average of $54.61. The company has a market capitalization of $2.58 billion, a P/E ratio of 18.92 and a beta of 0.95. National Health Investors has a twelve month low of $47.54 and a twelve month high of $62.93.

Insider Activity at National Health Investors

In other news, Director Charlotte A. Swafford bought 10,000 shares of the business's stock in a transaction that occurred on Tuesday, February 27th. The stock was acquired at an average cost of $58.69 per share, for a total transaction of $586,900.00. Following the purchase, the director now owns 110,185 shares of the company's stock, valued at approximately $6,466,757.65. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 7.26% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On National Health Investors

Several hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. lifted its position in National Health Investors by 1.0% during the first quarter. Vanguard Group Inc. now owns 6,404,110 shares of the real estate investment trust's stock worth $377,907,000 after acquiring an additional 60,990 shares during the last quarter. BlackRock Inc. lifted its position in National Health Investors by 1.3% during the second quarter. BlackRock Inc. now owns 4,220,046 shares of the real estate investment trust's stock worth $221,215,000 after acquiring an additional 54,952 shares during the last quarter. State Street Corp lifted its position in National Health Investors by 0.3% during the second quarter. State Street Corp now owns 2,191,956 shares of the real estate investment trust's stock worth $134,749,000 after acquiring an additional 5,762 shares during the last quarter. Principal Financial Group Inc. lifted its position in National Health Investors by 8.5% during the fourth quarter. Principal Financial Group Inc. now owns 1,870,632 shares of the real estate investment trust's stock worth $104,475,000 after acquiring an additional 146,735 shares during the last quarter. Finally, Geode Capital Management LLC lifted its position in National Health Investors by 1.5% during the second quarter. Geode Capital Management LLC now owns 933,049 shares of the real estate investment trust's stock worth $48,910,000 after acquiring an additional 13,654 shares during the last quarter. 62.51% of the stock is currently owned by institutional investors and hedge funds.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.